IL17A and autoimmune disease: On the other hand, several studies have shown that IL-17A can also contribute to the development of tissue damage produced by diverse pathological conditions, such as autoimmune diseases [73–75], liver and kidney diseases [76, 77], and chronic bacterial infection [78].